CSIMarket
 

Idexx Laboratories Inc  (NASDAQ: IDXX)

Idexx Laboratories Inc's

Competitiveness




 

IDXX Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Idexx Laboratories Inc reported Revenue increase in the 2 quarter 2026 by 9.73 % year on year.
The sales growth was above Idexx Laboratories Inc's competitors' average revenue growth of 5.47 %, achieved in the same quarter.

List of IDXX Competitors

With a net margin of 27.82 % Idexx Laboratories Inc achieved higher profitability than its competitors.

More on IDXX Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Idexx Laboratories Inc Net Income in the 2 quarter 2026 grew year on year by 15.11%, slower than its competitors' income growth of 232.15 %

<<  IDXX Stock Performance Comparisons


Idexx Laboratories Inc's Comment on Competition and Industry Peers


The company secures its intellectual property rights via patents, copyrights, trademarks, and trade secrets. It obtains these protections in the United States and internationally and licenses patents and technologies from third parties. No individual intellectual property right is deemed material to the overall business.



  

Overall company Market Share Q2 2026

With revenue growth of 9.73 % within Overall company, Idexx Laboratories Inc achieved improvement in market share, within Overall company to approximately 22.78 %.
<<  More on IDXX Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Idexx Laboratories Inc




Zoetis Inc
Share Performance



-42.03%
This Year



Zoetis Inc
Profile

Zoetis Inc operates as a global animal health company, offering a comprehensive range of medicines, vaccines, diagnostics, and services for both livestock and companion animals. Their business model emphasizes innovation in research and development to improve animal health, coupled with strong customer support, educational resources, and targeted solutions for veterinarians, livestock producers, and pet owners around the world.

More about Zoetis Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 30,492.100 mill. $ 9,517.000 mill. $ 2,616.000 mill.


Zomedica Corp
Share Performance



-3.61%
Over The Past 5 Days



Zomedica Corp
Profile

Zomedica develops and markets diagnostic and therapeutic products for companion animals.

More about Zomedica Corp 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 78.396 mill. $ 35.903 mill. $ -18.950 mill.


Neogen Corporation
Share Performance



+37.91%
This Quarter



Neogen Corporation
Profile

Neogen Corporation operates on a business model focused on developing and marketing various solutions for food and animal safety. They offer a wide range of products and services, including diagnostic tests, disinfectants, and animal genomics, catering to customers in the agricultural, food processing, and veterinary industries. By continually innovating and meeting industry regulations, Neogen Corporation aims to improve the safety and quality of food and animal products globally.

More about Neogen Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2,729.625 mill. $ 870.190 mill. $ -7.900 mill.


Novabridge Biosciences
Share Performance



-62.76%
This Year



Novabridge Biosciences
Profile

The company develops drug candidates and conducts related research and development activities in China.

More about Novabridge Biosciences's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 152.266 mill. $ - mill. $ -88.340 mill.


Immucell Corporation
Share Performance



+1.03%
This Quarter



Immucell Corporation
Profile

Immucell Corp's business model involves the development and commercialization of animal health products, particularly in the field of animal vaccines.

More about Immucell Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 89.872 mill. $ 29.777 mill. $ 0.787 mill.

2 more competitors available

Sign in to see all competitors

Sources: Idexx Laboratories Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Idexx Laboratories Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.